Using CAR‐NK cells to treat T‐ALL can resolve the problem of malignant T cell contamination, but CD38‐specific CAR‐NK cells would also cause fratricide as they also express CD38. This evidence concerns the gene CD38 and acute lymphoblastic leukemia.